HIGHLIGHTS
- who: Deepu Sharma et al. from the Department of Life Sciences, Shiv Nadar Institution of Eminence Deemed to Be University, G B Nagar Dist, Dadri, UP, India have published the article: Regorafenib and Ruthenium Complex Combination Inhibit Cancer Cell Growth by Targeting PI3K/AKT/ERK Signalling in Colorectal Cancer Cells, in the Journal: (JOURNAL) of 30/Dec/2022
- what: This study evaluates Ru-10 s activity against regorafenib-resistant HCT116 cells and as a therapeutic with Meanwhile the mechanism of the effect of Ru-1 alone and with as a is still unknown. Reg/Ru . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.